LONDON--GlaxoSmithKline PLC (GSK.LN) said Monday it is establishing a science committee to provide oversight of, and expertise to, the board regarding the company's research and development pipeline and scientific research strategy.

The committee will be chaired by non-executive director Jesse Goodman, who is the former chief scientist for the U.S. food and drug administration agency, the pharmaceutical company said.

Shares at 1525 GMT up 5.50 pence, or 0.4%, at 1513 pence valuing the company at GBP75.2 billion.

Write to Olga Cotaga at olga.cotaga@wsj.com, Twitter @OlgaCotaga

(END) Dow Jones Newswires

December 19, 2016 10:41 ET (15:41 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more GSK Charts.